Biogen Inc. (BIT:1BIIB)
162.15
+1.45 (0.90%)
Last updated: Mar 5, 2026, 11:34 AM CET
Biogen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,009 | 2,375 | 1,050 | 3,419 | 2,261 |
Short-Term Investments | 807.2 | - | - | 1,474 | 1,541 |
Cash & Short-Term Investments | 3,816 | 2,375 | 1,050 | 4,893 | 3,803 |
Cash Growth | 60.66% | 126.21% | -78.54% | 28.67% | 45.68% |
Accounts Receivable | 1,342 | 1,405 | 1,664 | 1,705 | 1,549 |
Other Receivables | 524.6 | 464 | 435.9 | 431.4 | 412.3 |
Total Trade Receivables | 1,867 | 1,869 | 2,100 | 2,136 | 1,962 |
Inventory | 2,168 | 2,461 | 2,527 | 1,344 | 1,352 |
Other Current Assets | 1,123 | 752.5 | 1,182 | 1,418 | 740.8 |
Total Current Assets | 8,974 | 7,457 | 6,859 | 9,791 | 7,857 |
Net Property, Plant & Equipment | 265.4 | 356.4 | 420 | 403.9 | 375.4 |
Other Intangible Assets | 9,179 | 9,691 | 8,363 | 1,850 | 2,221 |
Goodwill | 6,491 | 6,479 | 6,219 | 5,749 | 5,761 |
Long-Term Investments | 1,183 | 560.5 | 745 | 2,235 | 2,832 |
Other Long-Term Assets | 292.5 | 324.2 | 928.6 | 1,226 | 1,415 |
Total Assets | 29,440 | 28,049 | 26,845 | 24,554 | 23,877 |
Accounts Payable | 432 | 424.2 | 403.3 | 491.5 | 589.2 |
Accrued Expenses | 2,803 | 2,808 | 2,624 | 2,521 | 2,535 |
Current Portion of Long-Term Debt | - | 1,749 | 150 | - | 999.1 |
Other Current Liabilities | 114.8 | 548.3 | 257.4 | 259.9 | 174.7 |
Total Current Liabilities | 3,349 | 5,529 | 3,434 | 3,273 | 4,298 |
Long-Term Debt | 6,287 | 4,547 | 6,788 | 6,281 | 6,274 |
Long-Term Leases | 290.4 | 334.5 | 400 | 333 | 330.4 |
Other Long-Term Liabilities | 1,256 | 922.8 | 1,423 | 1,279 | 2,015 |
Total Long-Term Liabilities | 7,833 | 5,805 | 8,611 | 7,893 | 8,619 |
Total Liabilities | 11,183 | 11,333 | 12,045 | 11,166 | 12,918 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Treasury Stock | -2,977 | -2,977 | -2,977 | -2,977 | -2,977 |
Additional Paid-in Capital | 863.1 | 569.4 | 302.5 | 73.3 | 68.2 |
Accumulated Other Comprehensive Income | -182 | -136.2 | -153.7 | -164.9 | -106.7 |
Retained Earnings | 20,553 | 19,260 | 17,628 | 16,467 | 13,912 |
Total Common Shareholders' Equity | 18,257 | 16,716 | 14,799 | 13,398 | 10,896 |
Minority Interest | - | - | - | -9.5 | 63.5 |
Shareholders' Equity | 18,257 | 16,716 | 14,799 | 13,388 | 10,960 |
Total Liabilities & Equity | 29,440 | 28,049 | 26,845 | 24,554 | 23,877 |
Total Debt | 6,577 | 6,630 | 7,338 | 6,614 | 7,604 |
Net Cash (Debt) | -2,762 | -4,255 | -6,288 | -1,721 | -3,801 |
Net Cash Per Share | -18.77 | -29.17 | -43.19 | -11.79 | -25.41 |
Book Value | 18,257 | 16,716 | 14,799 | 13,398 | 10,896 |
Book Value Per Share | 124.11 | 114.57 | 101.64 | 91.77 | 72.84 |
Tangible Book Value | 2,587 | 545.9 | 217.2 | 5,799 | 2,914 |
Tangible Book Value Per Share | 17.59 | 3.74 | 1.49 | 39.72 | 19.48 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.